Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal CancerJames Biagi, Christopher M. Booth, Michael J. Raphael et al.|JAMA|2011Cited by 632
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialSun Young Rha, Xiaochun Zhang, Min‐Hee Ryu et al.|The Lancet Oncology|2023Cited by 614